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ABSTRACT
The sliding clamp Proliferating Cell Nuclear Antigen
(PCNA) functions as a recruiter and organizer of a
wide variety of DNA modifying enzymes including
nucleases, helicases, polymerases and glycosy-
lases. The 5’-flap endonuclease Fen-1 is essential
for Okazaki fragment processing in eukaryotes and
archaea, and is targeted to the replication fork by
PCNA. Crenarchaeal XPF, a 3’-flap endonuclease, is
also stimulated by PCNA in vitro. Using a novel con-
tinuous fluorimetric assay, we demonstrate that
PCNA activates these two nucleases by fundamen-
tally different mechanisms. PCNA stimulates Fen-1
by increasing the enzyme’s binding affinity for sub-
strates, as suggested previously. However, PCNA
activates XPF by increasing the catalytic rate con-
stant by four orders of magnitude without affecting
the KM. PCNA may function as a platform upon
which XPF exerts force to distort DNA substrates,
destabilizing the substrate and/or stabilizing the
transition state structure. This suggests that PCNA
can function directly in supporting catalysis as an
essential cofactor in some circumstances, a new
role for a protein that is generally assumed to per-
form a passive targeting and organizing function in
molecular biology. This could provide a mechanism
for the exquisite control of nuclease activity tar-
geted to specific circumstances, such as replication
forks or damaged DNA with pre-loaded PCNA.
INTRODUCTION
The Proliferating Cell Nuclear Antigen (PCNA) is a ring-
shaped protein that encircles DNA, acting as a sliding
clamp or platform. PCNA is conserved in eukarya and
archaea, and in bacteria the b subunit of DNA polymerase
III plays an analogous role. PCNA is an essential compo-
nent of the core processes of DNA replication, recombi-
nation and repair and cell-cycle control (1). PCNA is
loaded onto DNA at the replication fork by the clamp
loader Replication Factor C (RFC), and subsequently
recruits a variety of proteins to the fork. The interaction
between the 50-ﬂap endonuclease Fen-1 and PCNA is
essential for the recruitment of Fen-1 to replication
forks, where it catalyses Okazaki fragment processing.
Photobleaching experiments have shown that PCNA per-
sists for long periods at replication forks, whilst Fen-1 and
DNA ligase associate and dissociate rapidly—consistent
with the view that PCNA functions as a stable loading
platform for DNA modiﬁcation enzymes (2). Although
Fen-1 is quite active in the absence of PCNA in vitro,
disruption of the Fen-1:PCNA interaction leads to DNA
replication defects and newborn lethality in mice (3).
Disruption of the interaction between PCNA and mis-
match repair (MMR) proteins using an oligopeptide
abolishes MMR in an in vitro system (4). Similarly, dis-
ruption of PCNA:MMR protein interactions in
Saccharomyces cerevisiae abolishes MMR in meiotic
recombination in vivo (5). These observations emphasize
the important role of PCNA in vivo.
PCNA is generally considered to function as a DNA-
targeting factor, allowing non-sequence-speciﬁc enzymes,
such as DNA polymerases, endonucleases, ligases, heli-
cases, mismatch repair proteins and glycosylases to associ-
ate more closely with their DNA substrates [reviewed in
(6,7)]. The trimeric structure of PCNA yields three poten-
tial binding sites for proteins, leading to the suggestion
that PCNA may coordinate cellular processes by bringing
consecutive enzymes in a DNA processing pathway
together, for example, in the Okazaki fragment processing
pathway where the nuclease Fen-1, DNA ligase and DNA
polymerase can bind PCNA simultaneously (8). Covalent
modiﬁcation of PCNA by ubiquitination and sumolyation
has been shown to play an important role in damage
bypass pathways during replication in S. cerevisiae,
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merases and repair factors for the clamp (9,10).
Whilst the eukaryotic PCNA protein is a homotrimer,
in Sulfolobus solfataricus (and probably other crenarch-
aea) PCNA is heterotrimeric, with a tight association
between subunits 1 and 2 and a much weaker interaction
of the 1–2 heterodimer with subunit 3 that may facilitate
DNA loading (8). The structure of the PCNA heterotri-
mer has been solved both on its own (11) and as a complex
with Fen-1 (12,13) and DNA ligase (13), and closely
resembles the euryarchaeal and eukaryotic homotrimeric
protein structures. In addition to interactions with ligase,
Fen-1, DNA polymerases and glycosylases, S. solfataricus
PCNA stimulates the activities of the Holliday junction
endonuclease Hjc (14) and the 30-ﬂap endonuclease XPF
(15). We showed previously that PCNA stimulates the
cleavage activity of XPF for a wide variety of DNA sub-
strates to a remarkable degree (16,17). Here, we utilize a
novel ﬂuorescence resonance energy transfer (FRET)
assay to demonstrate that PCNA stimulates Fen-1 and
XPF in quite distinct ways. The activity of Fen-1 is
increased primarily by lowering the KM for substrates, as
was shown previously for the human proteins (18). This
represents the widely accepted DNA targeting model for
PCNA activation. In sharp contrast, PCNA is an essential
cofactor for the XPF nuclease, stimulating catalytic rates
by almost 10 000-fold. This is achieved by increasing the
maximal velocity of the DNA cleavage reaction, whilst
KM’s for substrates are not aﬀected. These data suggest
that PCNA increases the catalytic rate constant by redu-
cing the activation barrier of the cleavage reaction. This
represents a novel role for the PCNA sliding clamp that
may be relevant for other PCNA-dependent enzymes.
MATERIALS AND METHODS
Protein expression and purification
Sulfolobus solfataricus XPF and PCNA heterotrimer were
expressed and puriﬁed as described previously (8,16).
The S. solfataricus fen-1 gene was ampliﬁed from
S. solfataricus strain P2 genomic DNA using the following
primers:
50-primer:
50-CGTCGGATCCCCATGGATTTAGCAGA-TTTA
GTAAAAG
30-primer:
50-CCGGGGATCCGTCGACTTAAAACCA-TCTGT
CCAATCCTGTTTGTC
The PCR product was cloned into the NcoI/BamHI
sites of the vector pET28c (Novagen, Darmstadt,
Germany) for native protein expression. Protein expres-
sion was carried out in BL21 Rosetta (DE3) cells induced
by adding 0.2mM IPTG when cultures reached A600 0.7,
grown for further 3h and the cells pelleted. The bacterial
pellet was resuspended in  35ml lysis buﬀer (20mM MES
pH 6.0, 1mM EDTA, 0.5mM DTT, 100mM NaCl, 1mM
benzamidine) and sonicated for 4 2min with cooling.
The lysate was centrifuged at 48000g for 20min, 48C
and the supernatant heated to 708C to precipitate
Escherichia coli proteins before centrifugation for a
further 20min. The supernatant was ﬁltered (Acrodisc
0.1mM syringe ﬁlter, Pall Corporation, East Hills, NY,
USA) and diluted 3-fold with buﬀer A (20mM MES pH
6.0, 1mM EDTA, 0.5mM DTT). This was applied to a
5ml Hitrap heparin column (GE Healthcare, Chalfont St
Giles, UK) equilibrated with buﬀer A and the bound
cationic proteins eluted over a 120ml linear gradient of
0–1000mM NaCl. The fractions containing Fen-1 were
identiﬁed by SDS–PAGE, pooled and concentrated to
 7ml and loaded onto a HiLoad 26/60 Superdex 200
gel ﬁltration column (GE Healthcare) equilibrated with
buﬀer (20mM MES pH 6.0, 1mM EDTA, 0.5mM
DTT, 150mM NaCl). Fractions corresponding to the
peak(s) were concentrated as before and the protein con-
centration calculated from the extinction coeﬃcient at
280nm (15). Protein was stored at  808C in 15% glycerol
until required.
Substrateformation
Unlabelled oligonucleotides used to make the DNA struc-
tures were purchased from Operon Biotechnologies
GmbH (Cologne, Germany), the ﬂuorescent oligonucleo-
tides used were purchased from Integrated DNA
Technologies (Coralville, USA). The 30-ﬂap and 50-
double-ﬂap substrates were assembled using 0.1 OD of
each strand (Table 1) and mixed with hybridization
buﬀer (20mM Tris–HCl pH 7.8, 25mM NaCl). The
sample was then heated at 938C for 2min followed by
slow overnight cooling to 48C. The substrate was puriﬁed
on a 10% non-denaturing acrylamide gel at 110V for 4h
at 48C. Bands were visualized and cut by UV shadowing
and then extracted from the gel using a overnight crush
and soak protocol at 48C (CSH Protocols; 2006;
doi:10.1101/pdb.prot2936), followed by ethanol precipita-
tion. The absorption spectrum from 650nm to 220nm was
used to determine DNA concentration and labelling eﬃ-
ciency of the ﬂuorescent dyes. In addition, the sequences
of all oligonucleotides were selected to have predicted
melting temperatures >558C such that under reaction con-
ditions the duplex structure was favoured.
Endonuclease assays
Multiple turnover nuclease reactions were assembled in
30mM HEPES, pH 7.6, 40mM KCl, 5% glycerol,
0.1mg/ml bovine serum albumin with 25 nM labelled
DNA substrate and 1nM XPF dimer or FEN-1 monomer.
Table 1. Oligonucleotides used for DNA substrates
Oligo Sequence (50 to 30)
XPFA ACCGTCCG[dT-Fluo]CCTAGCAAGCATT[Cy3]
XPFB TCTGACTGCAGTCGGGCT
XPFC AGCCCGACAGCAGTCAGAGCTTGCTAGGAC
GGACGGT
FEN-1A ACCTAGGTCCGTCCTAGCAAGCC
FEN-1B [Cy3]TTATCTGACTGCAGTC[dT-Fluo]
AGCTACTG
FEN-1C CAGTAGCTAGACTGCAGTCAGAGCTT
GCTAGGACGGACCTAGGT
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added to the required concentration. When using short
synthetic DNA substrates, PCNA can diﬀuse readily
onto the DNA and there is no need for the addition of
the clamp loader RFC. Reactions were equilibrated at
558C for 10min before the reaction was initiated, readings
were then taken for 5min so that a stable baseline was
achieved. The reaction was initiated by the addition of
MgCl2 in 5% glycerol to a ﬁnal concentration of
10mM, and monitored to completion. To minimize eva-
poration a layer of mineral oil was added to prevent eva-
poration within the cell. Cleavage rates were calculated
by ﬁtting the raw data to a single exponential equation
generating reaction start and end point values. The Y-axis
was rescaled to reﬂect fmol product, and the reaction
rate was obtained by linear regression (fmol product/
min/fmol enzyme). Data were obtained in triplicate and
ﬁtted to the Michaelis–Menten equation by non-linear
regression.
Experiments were performed on a Cary Eclipse spectro-
ﬂuorimeter (Varian Inc., Palo Alto, USA) under magic
angle conditions to avoid anisotropy artefacts on the
ﬂuorescence signal, equipped with a Peltier temperature
controller set to 558C. All samples were ﬁltered before
analysis and analyzed via a time base scan
( ex=490nm,  em=520nm) in a Suprasil quartz cuvette
(10mm path) in a total volume of 150ml. Reactions were
equilibrated to the incubation temperature before initia-
tion of DNA cleavage as was evident by a steady back-
ground emission signal over 10min. Total cleavage of the
labelled oligonucleotide, conﬁrmed by PAGE, was deﬁned
as the maximum ﬂuorescence emission possible under
saturated cleaving conditions. Emission units were con-
verted to the amount of labelled oligonucleotide used
within a procedure, thereby equating labelled oligonucleo-
tide cleavage as a function of the emission of ﬂuorescence.
To achieve speciﬁc DNA substrate concentrations a con-
stant 25 nM of labelled DNA was used and unlabelled
DNA was added to the required concentration.
Experiments were performed over a range of PCNA con-
centrations to study the eﬀect of PCNA on the activity of
XPF and Fen-1. single-turnover assays were carried out in
the same way using the indicated concentrations of XPF
or Fen-1.
Isothermal titration calorimetry
Binding of XPF or Fen-1 to PCNA was assessed by iso-
thermal titration calorimetry (ITC) using a VP-ITC unit
operating at 328K for XPF and 293K for Fen-1
(Microcal, GE Healthcare, Chalfont St Giles, UK).
Before use, proteins were dialysed against binding buﬀer
and degassed in a vacuum. All concentrations were mea-
sured by UV absorption immediately before titrations
were started. For Fen-1, binding buﬀer was 30mM
HEPES pH 7.6, 40mM KCl and titrations comprised 50
injections of Fen-1, one 2-ml injection followed by 49 5-ml
injections. For XPF binding buﬀer was 50mM Tris–HCl
pH 7.4, 200mM NaCl and titrations comprised 26 injec-
tions of XPF, one 2-ml injection followed by 25 10-ml injec-
tions. The initial data point was routinely deleted to allow
for diﬀusion of ligand/receptor across the needle tip
during the equilibration period. Heats of dilution experi-
ments were measured independently and subtracted from
the integrated data before curve-ﬁtting in Origin 7.0 with
the standard one site model supplied by MicroCal.
RESULTS
Quantification ofXPF and Fen-1binding toPCNA
Both S. solfataricus XPF and Fen-1 have been shown
previously to interact with the heterotrimeric PCNA mole-
cule in the absence of DNA, but binding aﬃnities have not
been measured. We used ITC to determine the dissocia-
tion constants of both proteins for PCNA in solution.
Fen-1 bound to PCNA with a KD of 210 13 nM and a
stoichiometry of 0.998 0.002 Fen-1 monomer per PCNA
trimer (Figure 1A). XPF bound to PCNA with a stoichio-
metry of 1.1 0.2 XPF dimer per PCNA trimer and a KD
of 3.8 0.6mM (Figure 1B). By comparison, human
PCNA interacts with the mismatch binding protein
MutSa in solution with a 1:1 stoichiometry and a KD of
0.7mM (19).
Development ofacontinuous, fluorescence-based
assayfor XPFand Fen-1
Previous experiments on S. solfataricus XPF have utilized
a discontinuous, single-turnover assay with a radiolabelled
substrate (16). To facilitate analysis of multi-turnover
kinetics with a continuous assay, we developed a FRET-
based assay where the DNA strand targeted for cleavage
has two dyes: a donor dye (ﬂuorescein) located 50 to the
cleavage point and an acceptor dye (Cy3) located on the
terminus of the 30-ﬂap (Table 1, Figure 2). The close proxi-
mity of the donor and acceptor groups in the same DNA
strand facilitated eﬃcient energy transfer thereby reducing
ﬂuorescence emission intensity from the donor moiety at
520nm upon excitation at 490nm (Figure 2B). Cleavage
of the strand resulted in alleviation of this quenching and
an increase in ﬂuorescence emission intensity at 520nm.
The assay was based on a previously reported method
(20). The expected cleavage products of the ﬂuorescent
construct were observed by separating the reaction pro-
ducts by denaturing gel electrophoresis and visualization
by phosphorimaging (Fuji FLA5100, Fujiﬁlm, Tokyo,
Japan) using a SHG green laser (532nm) to observe Cy3
ﬂuorescence, conﬁrming that substrate strand cleavage
had taken place (Figure 2C).
A similar strategy was used to design a ﬂuorescent sub-
strate for Fen-1. The optimal double-ﬂap substrate was
chosen, which consists of an unpaired 30-nucleotide and
a5 0-ssDNA ﬂap (21). The donor dye (ﬂuorescein) was
located 30 of the cleavage point and the acceptor dye
(Cy3) was located on the terminus of the 50-ﬂap on the
same strand (Table 1, Figure 2A). Cleavage of the ﬂap by
Fen-1 resulted in an increase in ﬂuorescence emission of
the ﬂuorescein reporter at 520 nM that could be followed
in a continuous assay format as for XPF.
6722 Nucleic Acids Research, 2008, Vol. 36, No. 21Figure 1. Interaction of PCNA with XPF and Fen-1 quantiﬁed by ITC. (A) Quantiﬁcation of Fen-1 and PCNA interaction by ITC. Fen-1 (268mM
in the syringe) was injected into a solution of 13mM PCNA heterotrimer at 293K and heats of dilution monitored. The data were ﬁtted with a simple
one site binding model, yielding a KD of 210 nM and a binding stoichiometry of 1:1. (B) Quantiﬁcation of XPF and PCNA interaction by ITC. XPF
(170mM dimer in syringe) was injected into a solution of 4mM PCNA heterotrimer at 328K and heats of dilution monitored. The data were ﬁtted
with a simple one site binding model, yielding a KD of 3.8mM and a binding stoichiometry of 1:1.
Figure 2. A continuous ﬂuorescence assay for XPF and Fen-1. (A) Schematic showing design of steady-state FRET-based cleavage assays for XPF
and Fen-1. Refer to Table 1 for the sequences. (B) Progress of the XPF substrate cleavage by the XPF–PCNA holoenzyme can been monitored by
the increase in the donor (ﬂuorescein) emission at 520nm. The solid line represents the ﬁtting of the experimental data to a single exponential model.
Inset: change in the ﬂuorescence emission spectrum ( exc 490nm) observed upon substrate cleavage by XPF–PCNA. The emission spectrum before
initiation of the reaction by addition of magnesium (pink), and (yellow) are shown. (C) Denaturing gel electrophoresis conﬁrms that the ﬂuorescent
XPF substrate is cleaved by XPF–PCNA.
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Single-turnover experiments were performed over a tem-
perature range from 258Ct o5 5 8C. The XPF concentra-
tion was 1mM and DNA substrate concentration 80nM.
Data are shown graphically in Figure 3A and summarized
in Table 2. Experiments performed at 558C in the presence
of 1mM PCNA yielded a kc value of 9.1min
 1. This com-
pares well with the rate of 6.8min
 1 estimated using a
discontinuous radiation-based assay (16), giving conﬁ-
dence that the ﬂuorescent labels did not interfere with
catalysis by XPF. Experiments performed under identical
conditions but without added PCNA yielded a kc value
of 1 10
 3min
 1,  7000-fold less active than in the pre-
sence of PCNA (Figure 3B, Table 2). This is clear evidence
that PCNA activates the catalytic cleavage activity of
XPF, presumably by stabilizing the transition state or
destabilizing the substrate. In marked contrast, single-
turnover rate constants for Fen-1 in the presence and
absence of 1mM PCNA yielded highly similar kc values
of 10.3min
 1 and 10.6min
 1, respectively, at 558C, sug-
gesting there is no intrinsic stimulation of the catalytic step
of Fen-1 by PCNA (Figure 3B, Table 2). Both enzymes
showed temperature-dependent kinetics as expected, with
a 2- and 3-fold increase in catalytic rate for every 108C
increase in temperature for Fen-1 and XPF, respectively.
Steady-statekinetic analysesof XPF andFen-1
The pre-steady-state rate constants measured for XPF
highlighted the crucial role of PCNA in the activation of
catalysis by this endonuclease, and conﬁrmed previous
measurements using discontinuous assays. The ﬂuores-
cence-based assay allowed measurement of steady-state
kinetics for XPF, which yield complementary information
on the cycle of binding, catalysis and product release.
Steady-state kinetic measurements of XPF were carried
out by assaying 1 nM XPF and a DNA substrate concen-
tration range of 25–650 nM at 558C. Initial velocities at
each substrate concentration (Figure 4A) were ﬁtted to the
Michaelis–Menten equation (Figure 4B) to yield kinetic
constants kcat and KM. Steady-state experiments in the
absence of PCNA showed no activity for XPF over a
time period of 72h. Inclusion of PCNA at concentrations
from 50 nM to 20mM increased the kcat from 0.37min
 1
to 5.5min
 1 (Figure 4C), without changing the KM which
remained constant at 85 10 nM at all concentrations of
PCNA tested (Figure 4D). The close agreement between
the catalytic rate constant kc and the turnover number
kcat, 9.1min
 1 and 5.5min
 1, respectively, suggests that
the catalytic step, rather than substrate binding or product
release by XPF, is rate-limiting. The variation of kcat with
PCNA concentration shown in Figure 4C yielded an
apparent KM of 4 0.7mM for XPF and PCNA. This
was in good agreement with the KD of 3.8mM determined
from the ITC experiment, reinforcing the conclusion that
the PCNA–XPF complex is essential for nuclease activity.
Steady-state kinetic analysis was also carried out for
Fen-1. As observed previously, Fen-1 activity was not
strictly dependent on the presence of PCNA. An  3-fold
increase in kcat from 2.6min
 1 to 7.3min
 1 was observed
Figure 3. DNA substrate cleavage by XPF and Fen-1 in the presence and absence of PCNA. (A) Representative traces showing the continuous
monitoring by FRET of DNA substrate cleavage and product formation by the XPF–PCNA complex at diﬀerent temperatures under single-turnover
conditions. (B) Variation in the catalytic rate constants for DNA substrate cleavage by 1mM XPF or Fen-1 in the presence and absence of 10mM
PCNA as a function of temperature. Fen-1 is not signiﬁcantly stimulated by PCNA under single-turnover conditions, whilst XPF is only marginally
active in the absence of PCNA. Experiments were carried out in triplicate and means with standard errors are shown.
Table 2. Summary of kinetic parameters determined for XPF and Fen-1 in the presence and absence of PCNA
kc (min
 1) kcat (min
 1) KM (M) kcat/KM (M
 1min
 1)
XPF (1.0 0.2) 10
 3 –– –
XPF+PCNA 9.1 0.3 5.5 0.2 (93 8) 10
 9 (59 7) 10
6
Fen-1 10.6 0.9 2.6 0.2 (290 40) 10
 9 (9 2) 10
6
Fen-1+PCNA 10.3 0.3 7.3 0.3 (67 10) 10
 9 (110 16) 10
6
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(Figure 4C). In contrast to XPF, the KM for Fen-1
was strongly dependent on PCNA concentration, drop-
ping from 290 nM to 60 nM as PCNA increased from
0mMt o5 mM (Figure 4D). Together with the single-
turnover experiments, this suggests that the stimulatory
eﬀect of PCNA on Fen-1 is largely related to substrate
binding.
DISCUSSION
Stimulation of Fen-1by PCNA—substrate targeting
The sliding clamp PCNA binds to DNA and interacts with
a wide variety of proteins. It is generally accepted that
PCNA’s function is to recruit a variety of DNA modiﬁca-
tion proteins to relevant DNA structures. This implies a
rather passive role in catalysis, as a moderately
stimulatory factor whose main function is in targeting
and organization of components of quite complex mole-
cular machines catalysing processes, such as DNA replica-
tion or MMR. Virtually all previously described PCNA-
interacting proteins are reasonably active in the absence of
PCNA. A good example is the 50-ﬂap endonuclease Fen-1,
whose activity is only moderately stimulated by PCNA
in vitro. Nevertheless, interactions with PCNA have been
shown to be crucial for cell survival in vivo (3), emphasiz-
ing the role of PCNA as a molecular organizer or
mediator.
Previously published kinetic studies of human and
archaeal Fen-1’s have reported widely divergent kinetic
constants. In several instances, this has been complicated
by reporting of multiple turnover rate constants and KM’s
derived from assays where Fen-1 was equimolar to or in
excess of the substrate concentration. Some Fen-1’s seem
to be highly sensitive to the presence of DTT for full
Figure 4. Multiple turnover kinetic analyses of XPF and Fen-1. (A) Representative data showing the reaction progress of multiple turnover catalysis
of 1nM XPF and 10mM PCNA at 558C with respect to DNA substrate concentration. (B) Plot showing the dependence of XPF catalytic rate on
DNA concentration at a variety of PCNA concentrations from 0mMt o2 0 mM. The data were ﬁtted to the Michaelis–Menten equation. (C) Plot
showing the variation in rate constant kcat for XPF (blue) and Fen-1 (red) with respect to PCNA concentration. (D) Plot showing the variation in
Michaelis constant KM for XPF (blue) and Fen-1 (red) with respect to PCNA concentration. KM values for XPF are not aﬀected by alterations in
PCNA concentration, whilst those for Fen-1 are strongly dependent on the concentration of PCNA. All data points in (B–D) are the means of
triplicate experiments and standard errors are shown.
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has varied widely. The continuous ﬂuorescent assay
system we have reported here has clear advantages over
discontinuous assays used previously. The single-turnover
rate (kc) for S. solfataricus Fen-1 of 10.3min
 1 was close
to the multiple turnover kcat of 7.3min
 1 suggesting that,
as with XPF, the catalytic step is rate limiting under the
multiple turnover conditions used in these experiments.
This contrasts with the phage T5-ﬂap endonuclease,
where turnover rates are limited by product release
rather than the catalytic step (22).
The kcat for human Fen-1 in the absence of PCNA, with
a double-ﬂap substrate at pH 8.0, 378C, is reported as
11min
 1 (23). The turnover number for Archaeoglobus
fulgidus Fen-1 is reported to be considerably higher,
about 100min
 1 with a similar substrate at pH 9.3, 558C
and a large increase in reaction rate was observed when
1mM DTT was present in the reaction buﬀer (22). We
observed no inﬂuence of DTT on the cleavage rate of S.
solfataricus Fen-1, and note that whilst A. fulgidus Fen-1
has a single cysteine residue that may conceivably inﬂu-
ence catalysis, S. solfataricus Fen-1 has no cysteines in its
primary sequence. However, we did observe an  10-fold
increase in both the single- and multiple-turnover rate
constants for S. solfataricus Fen-1 assayed at pH 9.3,
bringing the catalytic constants close to those reported
for A. fulgidus Fen-1 (22) (data not shown). In common
with studies of other Fen-1 enzymes, we have shown that
S. solfataricus Fen-1 is only moderately stimulated by
PCNA and that this eﬀect is mostly at the level of DNA
binding. Under single-turnover conditions, PCNA has no
eﬀect on Fen-1 activity. Under steady-state conditions, the
KM of S. solfataricus Fen-1 for a double-ﬂap substrate was
reduced from 290 nM in the absence of PCNA to 60 nM at
saturating concentrations of PCNA. By comparison, the
KM of A. fulgidus Fen-1 for a double-ﬂap substrate was
estimated at 1.4mM in the absence of PCNA (22). In reac-
tions carried out at pH 9.3, the eﬀect of PCNA (20mM) on
S. solfataricus Fen-1 activity was qualitatively similar to
that observed at pH 7.6, with a modest increase in Vmax
and a 4-fold decrease in KM. This suggests that the
mechanism by which PCNA stimulates Fen-1 is similar
at both the high and low pH’s, and is likely to be a general
phenomenon for Fen-1’s from diﬀerent organisms.
Stimulation ofXPF by PCNA—an essential
cofactorforcatalysis
In sharp contrast to the situation for Fen-1, the 30-ﬂap
endonuclease XPF has a 7000-fold lower catalytic rate
constant in the absence of PCNA. Under steady-state con-
ditions, activity was undetectable in the absence of PCNA,
and increasing concentrations of PCNA resulted in an
increase kcat but had no eﬀect on KM. These observations
suggest strongly that the role of the sliding clamp in the
XPF-mediated reaction is fundamentally diﬀerent from
that observed with Fen-1 and other DNA modiﬁcation
enzymes. Here, PCNA must be regarded as an essential
cofactor or protein subunit of the XPF holoenzyme. In
other words, the XPF:PCNA complex is the active
entity. Consistent with this hypothesis, the variation of
XPF kcat with increasing PCNA concentration yields an
apparent KM for PCNA of 4mM—in close agreement with
the dissociation constant of the two proteins in solution
measured by ITC at 3.8mM.
Why is PCNA absolutely essential for catalysis by cre-
narchaeal XPF when its role in other situations is predo-
minantly in substrate targeting and processivity? The XPF
endonuclease is unusual in being organized with two
dimeric domains joined by a ﬂexible linker (24)
(Figure 5). The C-terminal dimeric HhH2 domain has
a DNA-binding role, and is thought to distort DNA
substrates, allowing the nuclease domain to remove the
30-ﬂap, or extend the gap upstream of a nicked DNA
duplex. It is possible that PCNA functions as a molecular
fulcrum in this situation; acting as a platform against
which XPF can exert force to distort the DNA substrate
and drive it towards the transition state (Figure 5B).
This scenario can be viewed as a particular form of
DNA targeting, as the XPF nuclease will only cleave
substrates where PCNA is appropriately located in vivo.
The activity of sequence non-speciﬁc nucleases must be
controlled tightly in vivo to avoid non-speciﬁc DNA diges-
tion. For example, cellular Holliday junction resolving
enzymes are exquisitely speciﬁc for four-way DNA
Figure 5. Scale cartoon showing a potential mechanism for PCNA
activation of XPF endonuclease activity. (A) PCNA loaded onto
duplex DNA can associate reversibly with the XPF endonuclease,
which is composed of two dimeric domain joined by a ﬂexible linker
and binds to PCNA via a C-terminal PIP motif. (B) On encountering a
suitable substrate for XPF, such as a 30-ﬂap, PCNA acts as a molecular
fulcrum, providing a platform against which XPF can exert force to
distort the DNA towards a productive structure for catalysis.
6726 Nucleic Acids Research, 2008, Vol. 36, No. 21junctions, whilst phage resolving enzymes, such as T4
endonuclease VII are more promiscuous and thus highly
toxic when overexpressed in E. coli (25). The absolute
dependence of XPF on PCNA for activity may therefore
reﬂect an elegant control mechanism to limit the nuclease
activity not only to particular DNA substrates, but to
places such as replication forks where PCNA is loaded.
This could ensure that subsequent PCNA-dependent reac-
tions, such as DNA replication or ligation that are neces-
sary following DNA cleavage by XPF are undertaken
eﬃciently.
In summary, we have shown that the sliding clamp
PCNA can stimulate catalysis by endonucleases by two
quite diﬀerent mechanisms. There may be other examples
of apparently inactive nucleases that in fact have an abso-
lute requirement for an interaction with the sliding clamp.
Such mechanisms may ensure that nuclease activities
are kept tightly regulated to prevent non-speciﬁc DNA
cleavage.
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